Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder

Clinical trial NCT00730691 · COMPLETED

Trial details

NCT number: NCT00730691
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2008-06-01
Primary completion: 2009-02-01
Enrollment: 781

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.